| Andrea Dellinger, | |
|
32 Fairfax Ave, Asheville, NC 28806-3222 | |
| (828) 230-5464 | |
| (828) 225-2761 |
| Full Name | Andrea Dellinger |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 32 Fairfax Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386067965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 8612 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Dellinger, 32 Fairfax Ave, Asheville, NC 28806-3222 Ph: (828) 230-5464 | Andrea Dellinger, 32 Fairfax Ave, Asheville, NC 28806-3222 Ph: (828) 230-5464 |
News Archive
The Washington Post as part of a four-day series, titled "Careless Detention," is examining how some immigrants to the U.S. do not receive needed health care while in immigration detention centers.
In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
Cytopia Limited today announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline of kinase inhibitors, a class of targeted therapeutics that is one of the fastest growing segments of the cancer drug market.
Rates of oropharangeal cancer have increased by around 50 per cent in the last 20 years, according to a report in the British Medical Journal.
› Verified 6 days ago
Ms. Erin Spainhour, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 85 W Walnut St, Apt. 406, Asheville, NC 28801 Phone: 336-592-5882 | |
Jennifer Yoelson Frome, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Brevard Rd, Asheville, NC 28806 Phone: 828-772-7101 | |
Mr. Samuel Clemons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Concord Pl, Asheville, NC 28803 Phone: 828-620-0729 | |
Melissa May Larsen, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Summit Ave, Ste. B, Asheville, NC 28803 Phone: 828-670-8056 Fax: 828-670-8057 | |
Sterling Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Kenilworth Rd, Asheville, NC 28803 Phone: 828-367-7044 | |
Melody Coffel, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Alclare Dr, Asheville, NC 28804 Phone: 407-222-2970 | |
Samantha Campbell, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 856 Sweeten Creek Rd Ste F, Asheville, NC 28803 Phone: 828-684-7337 |